In recent years, numerous tennis stars have engaged in highly profitable investments, and now world No. 1 Aryna Sabalenka seeks to join this elite group. She has partnered with football icon David Beckham to support the all-in-one daily supplement brand, IM8.
Sabalenka has become a shareholder in the company, which is spearheaded by Beckham. Her growing prominence as a global sports star is evident, becoming attractive to brands eager to promote their offerings.
The choice of IM8 to not only appoint Sabalenka as a brand ambassador but also offer her shares indicates their ambition to cultivate a lasting relationship with the player, who recently celebrated her second US Open victory.
IM8, founded by Beckham in collaboration with biotech firm Prenetics, provides a comprehensive daily powder featuring 92 ingredients along with capsules aimed at enhancing cellular health.
These products are created to streamline wellness by blending scientifically validated formulations with natural ingredients to promote eight vital health areas, including energy, immunity, and digestion. Sabalenka has expressed her satisfaction with the outcomes.
Insights from Sabalenka
Sabalenka stated, “From the first time I picked up a racket at six in Minsk, my quest for excellence has been unending. Every practice, every game, and every tournament is about pushing limits and finding that competitive edge. As the current World No. 1, I understand the demands of top-level competition.”
She emphasizes that her partnership with IM8 is more than a mere endorsement; it’s a crucial element of her training regimen and a key component in her success. As she reflects on her journey, Sabalenka highlights her challenges and the tenacity required to overcome them, stating, “You have to fight till the end.” With her fierce determination, she has secured four Grand Slam titles and several WTA 1000 victories.
According to Sabalenka, her quest in early 2025 for a streamlined nutrition regimen led her to IM8 Daily Ultimate Essentials. She quickly noticed improvements in her energy, recovery, focus, and digestion—game-changing factors for high-level competition. As she found genuine utility in the product, her connection to IM8 deepened, and she expressed a desire to be involved with something that aligns with her commitment to quality and excellence.
If IM8 achieves similar success to Roger Federer’s investment in the On shoe brand, which is rumored to be worth over $400 million, Sabalenka will undoubtedly hit a significant milestone with her latest venture.
READ NEXT: Alcaraz, Swiatek, Sinner, Sabalenka push for more money and reform as Djokovic notably absent
